43 results
8-K/A
EX-99.2
0skuf4
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K/A
EX-99.1
zk897dkbn p3ggqj6
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K
EX-2.1
uoz6njejk jbo
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
PRE 14A
92mkrecq1wjwjnzsmu7
4 Apr 23
Preliminary proxy
4:33pm
8-K
EX-3.2
dhr0kb09
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
8-K
EX-2.1
ocbk34a bvrrrm55juw
12 May 22
Entry into a Material Definitive Agreement
5:12pm
POS AM
nimdc
4 Mar 22
Prospectus update (post-effective amendment)
4:04pm